Concepedia

Publication | Open Access

PHOTOCOAGULATION VERSUS RANIBIZUMAB FOR PROLIFERATIVE DIABETIC RETINOPATHY

DOIFull Paper Access

17

Citations

17

References

2019

Year

Susan B. Bressler, Wesley T. Beaulieu, Adam R. Glassman, Jeffrey G. Gross, Michele Melia, Eric Chen, Michael R. Pavlica, Lee M. Jampol
Retina

Abstract

There were no characteristics identified in which outcomes were superior with PRP compared with ranibizumab. These exploratory analyses provide additional support that ranibizumab may be a reasonable alternative to PRP for proliferative diabetic retinopathy over a 2-year period.

References

YearCitations

Page 1